Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 999302 dose-finding trial for final follicular maturation trigger in women undergoing controlled ovarian stimulation
2022-000753-80Phase 2Terminated
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of choriogonadotropin beta in female infertility (5 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Number of metaphase II oocytes. Started Jun 2022; status: terminated.
02
Drugs
choriogonadotropin beta
03
Conditions
female infertility
Beyond the preview
Go deeper on 2022-000753-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000753-80.